TERPENOID DERIVATIVE

Provided is a novel terpenoid derivative which exhibits anti-inflammatory action and cytoprotective action by activating Keap1/Nrf2/ARE signal transduction pathways. Terpenoid derivative A is represented by formula (1). L'invention concerne un nouveau dérivé terpénoïde présentant une action ant...

Full description

Saved in:
Bibliographic Details
Main Authors HATANO, EMIKO, OHNUKI, TAKASHI, KOMORIYA, SATOSHI, NAKAGAMI, YASUHIRO, MASUDA, KAYOKO, ONO, YASUNORI, IIZUKA, MAYUMI
Format Patent
LanguageEnglish
French
Japanese
Published 25.09.2014
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
STEROIDS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:Provided is a novel terpenoid derivative which exhibits anti-inflammatory action and cytoprotective action by activating Keap1/Nrf2/ARE signal transduction pathways. Terpenoid derivative A is represented by formula (1). L'invention concerne un nouveau dérivé terpénoïde présentant une action anti-inflammatoire et cytoprotectrice en activant les voies de transduction de signaux Keap1/Nrf2/ARE. Le dérivé terpénoïde A est représenté par la formule (1).
Bibliography:Application Number: WO2014JP57222